Argumentative Essay Outline
21 November 2018
Much debate has been introduced regarding the legalization and medical use of marijuana. There are many testimonies of the successful use of marijuana for medical purposes and legally prescribed medications. Medical marijuana or cannabis is a drug, which provides great relief to cancer patients, patients with epilepsy, glaucoma, HIV and AIDS, those suffering from post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn's disease, Parkinson's disease, Multiple sclerosis (MS), and other similar medical conditions.
In marijuana, opioids perform a function of neurotransmitters because they send chemical signals to nerve cells throughout the nervous system. Researchers admit that 10mg of marijuana is one dose can be compared with one beer. This dosage influences a patient with chronic pain positively (Russo, 2016).
Converting medical marijuana industry into a state-owned one will bring to the state millions of dollars each month. The illegal market is about 36$ billion dollar industry, and medical marijuana prescribed for clear medical standards will benefit the economy (D'Ambrosio, 87).
Illegal marijuana farming hurts the environment and leads to soil erosion. The state has to impose new environmental standards on the medical use and authorized supply of this drug (D'Ambrosio, 51).
Some negative feelings may expand to paranoia, distrust, fear, panic, feeling of pain, and psychosis. The main effects involve altered senses, mood changes, irrational behavior, impaired body movement, problems with memory. Also, different effects are breathing problems, increased heart rates, hallucinations, temporary paranoia, etc. (D'Ambrosio, 24).
In sum, legalized medical marijuana has a great positive impact on human health, medical conditions of terminally ill-patients, the
D'Ambrosio, F. Cannabis Is Medicine. The A-Z of Medical Marijuana (Introduction).
Russo, E. B. “Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues.”
Front. Pharmacology, (2016): 12-29.
Sachs, J., McGlade, E., and Yurgelun-Todd, D. “Safety and Toxicology of
Cannabinoids.” Neurotherapeutics, vol. 12, no. 4, (2015): 735–746.